P-006 YI Severe Colitis Induced by Rituximab
نویسندگان
چکیده
منابع مشابه
Rat colitis induced by intrathecal injection of substance P.
The aim of this study was to, from the point of neurogenic inflammation, explore the pathogenesis of colitis and to provide direct evidence for the neurogenic colitis hypothesis. Male Sprague-Dawley rats (180-220 g) anesthetized with chloral hydrate were intrathecally (ith) implanted with polyethylene-10 (PE-10) catheter to reach the spinal cord T₁₂-L₅ level. Substance P (SP) was ith injected o...
متن کاملFulminant Colitis Following Rituximab Therapy.
Rituximab (RTX; Rituxan, Genentech) is the clinical formulation of a murine immunoglobulin G (IgG) 1 monoclonal anti-CD20 antibody and is widely used in the initial treatment of CD20-positive hematologic malignancies and a variety of autoimmune disorders. Rarely, fulminant colitis has been reported with the use of RTX (Table).1-7 We report a patient who developed 2 episodes of fulminant colitis...
متن کاملP 97: Neurodegeneration Induced by Tau protein
Tau is one of several types of microtubule-associated proteins (MAPs), responsible for the assembly and stability of microtubule networks that is present only in neurons and predominantly localized in axons which its functions are tightly regulated by phosphorylation. Via as yet unknown mechanisms, tau becomes hyperphosphorylated and accompanies with neuronal degeneration, loss of synapses...
متن کاملCorticosteroid treatment of severe, non-responsive Clostridium difficile induced colitis.
Clostridium difficile can cause inflammatory diarrhoea and colitis by disrupting normal colonic flora. Corticosteroids are effective against diarrhoea associated with inflammatory bowel disease, but their effectiveness in treating inflammatory diarrhoea of C difficile has not been reported. In this preliminary report, we describe the use of corticosteroids in a child with severe C difficile dia...
متن کاملAmelioration of Severe TNBS Induced Colitis by Novel AP-1 and NF-κB Inhibitors in Rats
AP-1 and NF-κ B inhibitors, namely, DTCM-G and DHMEQ, were investigated in male Wistar rats with severe colitis, induced by TNBS. The animals were randomized into 3 groups. The control group received 0.5 mL of 0.5% of the vehicle i.p., the DTCM-G group received 22.5 mg/kg body weight DTCM-G in 0.5% i.p., and the DHMEQ group received 15 mg/kg body weight DHMEQ i.p., all twice daily for 5 days. T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Inflammatory Bowel Diseases
سال: 2014
ISSN: 1078-0998
DOI: 10.1097/01.mib.0000456765.16886.39